Sign in

CIK 0001636282 · Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464312787
Phone
6176515940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. SC 13G Stake Amended Statement of Ownership
  11. 8-K Event Shareholder vote results
  12. 8-K Event Other events
  13. 8-K Event Material agreement
  14. 424B5 Offering Prospectus
  15. 424B5 Offering Prospectus
  16. 8-K Event Material agreement
  17. FWP Offering Free Writing Prospectus
  18. 10-Q Report Quarterly Report
  19. 8-K Event Results of operations · Regulation FD disclosure
  20. DEF 14A Proxy Proxy Statement

Page 21 of 42 · 823 filings